Orchestra BioMed Holdings, Inc. Ordinary Shares OBIO
$5.41
-0.38%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $13.00
- Implied Upside
- +140.3%
- Price Target Range
- $10.00 – $20.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-11 | Piper SandlerMatt O'Brien |
Reiterates | Overweight | $9 → $10 |
| 2026-05-19 | B. Riley SecuritiesKyle Bauser |
Maintains | Buy | $12 → $10 |
| 2026-05-14 | HC Wainwright & Co.Yi Chen |
Reiterates | Buy | $10 |
| 2026-05-13 | BarclaysMatt Miksic |
Maintains | Overweight | $12 → $13 |
| 2026-03-12 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2026-01-09 | BarclaysMatt Miksic |
Maintains | Overweight | $11 → $12 |
| 2025-12-10 | TD CowenJoshua Jennings |
Initiates coverage on | Buy | $15 |
| 2025-11-13 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2025-11-12 | BarclaysMatt Miksic |
Maintains | Overweight | $12 → $11 |
| 2025-09-04 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $12 → $10 |
| 2025-08-20 | BTIGMarie Thibault |
Downgrades | Buy → Neutral | — |
| 2025-08-13 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2025-08-07 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2025-05-13 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2025-05-05 | BarclaysMatt Miksic |
Maintains | Overweight | $16 → $12 |
| 2025-04-22 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2025-04-04 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $14 → $12 |
| 2025-04-01 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2025-03-20 | BTIGMarie Thibault |
Initiates coverage on | Buy | $12 |
| 2025-03-10 | HC Wainwright & Co.Yi Chen |
Reiterates | Buy | $14 |
| 2025-01-02 | BarclaysMatt Miksic |
Initiates coverage on | Overweight | $16 |
| 2024-11-15 | HC Wainwright & Co.Yi Chen |
Reiterates | Buy | $14 |
| 2024-11-13 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2024-08-22 | HC Wainwright & Co.Yi Chen |
Initiates coverage on | Buy | $14 |
| 2024-07-25 | B. Riley SecuritiesKyle Bauser |
Initiates coverage on | Buy | $15 |
| 2024-06-12 | Chardan CapitalKeay Nakae |
Reiterates | Buy | $20 |
| 2024-03-28 | Chardan CapitalKeay Nakae |
Maintains | Buy | $20 |
| 2024-01-19 | JefferiesMatthew Taylor |
Initiates coverage on | Buy | $14 |
| 2023-08-11 | Chardan CapitalKeay Nakae |
Reiterates | Buy | $20 |
| 2023-08-09 | Chardan CapitalKeay Nakae |
Reiterates | Buy | $20 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.41
- Market Cap
- $326.37 million
- 52-Week Range
- $2.20 – $5.78
- Average Volume
- 290K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.